Document is current
Any future updates will be listed below
-
Authors
Rodríguez-Martínez, Alejandro
Giraldo-Ruiz, Lucía
Ramos, María C.
Luque, Irene
Ribeiro, Diogo
Postigo-Corrales, Fátima
Alburquerque-González, Begoña
Montoro-García, Silvia
Arroyo-Rodríguez, Ana Belén
Conesa-Zamora, Pablo
Hurtado, Ana María
Luengo-Gil, Ginés
Pérez-Sánchez, Horacio
-
Funding
Funding for this research was provided by:
Fundación Científica Asociación Española Contra el Cáncer (PRDMU246084RODR)
Junta de Andalucía (P18-RT-1193)
Horizon 2020 (GA848098, GA848098)
Instituto de Salud Carlos III (PI23/00601, PI23/00601)
- License Information
-
More Information
Article History
Received: 7 January 2025
Accepted: 28 March 2025
First Online: 28 April 2025
Declarations
:
: The authors declare no competing interests.
: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of the Santa Lucía University General Hospital (protocol code: REVERT, date of approval: 06/02/2021). All procedures performed in this study involving patients and human subjects were in accordance with the ethical standards of the institutional research committee and the Declaration of Helsinki. For human-derived organoids, written informed consent was obtained in previous studies, and patients authorized the use of their samples in other research studies.
